Cobro Ventures logo

Cobro Ventures

North America, Virginia, United States, Arlington

Description

Cobro Ventures is a private investment firm that invests in software and biotech companies.

Investor Profile

Cobro Ventures has made 9 investments, with 0 in the past 12 months and 56% as lead.

Stage Focus

  • Series B (44%)
  • Series A (33%)
  • Seed (11%)
  • Series C (11%)

Country Focus

  • United States (89%)
  • Israel (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Genetics
  • Health Diagnostics
  • Artificial Intelligence (Ai)
  • Manufacturing
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cobro Ventures frequently co-invest with?

CS
North America, New Jersey, United States, Morristown
Co-Investments: 1
Taiwania Capital Management Corporation
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 4
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
Axil Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
LC
North America, Missouri, United States, St Louis
Co-Investments: 2
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 2
RC
North America, Massachusetts, United States, Cambridge
Co-Investments: 4

What are some of recent deals done by Cobro Ventures?

AI Proteins

Boston, Massachusetts, United States

AI Proteins is a biotechnology company that focuses on designing and engineering of synthetic miniprotein therapeutics.

Artificial Intelligence (AI)BiotechnologyTherapeutics
SeedNov 3, 2022
Amount Raised: $18,200,000
NextRNA Therapeutics

Cambridge, Massachusetts, United States

NextRNA Therapeutics creates targeted therapeutics with the aim of discovering novel ncRNAs that cause disease.

BiotechnologyHealth CareTherapeutics
Series AMar 1, 2022
Amount Raised: $46,800,000
Windgap Medical

Somerville, Massachusetts, United States

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies.

BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Series BJan 20, 2022
TechsoMed

Rehovot, HaMerkaz, Israel

Ultrasound based real-time monitoring systems for thermal ablation procedures

BiotechnologyHealth Care
Series BMar 3, 2021
Amount Raised: $7,000,000
C4 Therapeutics

Cambridge, Massachusetts, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Health DiagnosticsMedicalTherapeutics
Series BJun 16, 2020
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series CJul 23, 2019
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series BJan 7, 2019
Amount Raised: $42,000,000
Frequency Therapeutics

Lexington, Massachusetts, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

BiotechnologyGeneticsHealth CareMedical
Series AApr 11, 2017
Amount Raised: $32,000,000
C4 Therapeutics

Cambridge, Massachusetts, United States

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Health DiagnosticsMedicalTherapeutics
Series AJan 7, 2016
Amount Raised: $73,000,000